Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Ramos Membrive, R."'
Autor:
Durán-Lobato M; Center for Research in Molecular Medicine & Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, Spain; Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, Spain; Department of Pharmacology, Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain; Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Sevilla, Prof. García González, 2, 41012 Seville, Spain., Tovar S; Center for Research in Molecular Medicine & Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, Spain; Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Madrid, Spain., Cuñarro J; Center for Research in Molecular Medicine & Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, Spain; Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, Spain., Ramos-Membrive R; Radiopharmacy Unit, Department of Nuclear Medicine, Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Av. Pío XII 36, 31008 Pamplona, Spain; Translational Molecular Imaging Unit, Department of Nuclear Medicine, Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Av. Pío XII 36, 31008 Pamplona, Spain., Peñuelas I; Radiopharmacy Unit, Department of Nuclear Medicine, Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Av. Pío XII 36, 31008 Pamplona, Spain; Translational Molecular Imaging Unit, Department of Nuclear Medicine, Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Av. Pío XII 36, 31008 Pamplona, Spain., Marigo I; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Benetti F; ECSIN-European Center for the Sustainable Impact of Nanotechnology, ECAMRICERT SRL, Padova, Italy., Chenlo M; Neoplasia & Endocrine Differentiation P0L5, Centre for research in Molecular Medicine and Chronic Disease (CIMUS), Av Barcelona s/n, 15782 Santiago de Compostela, Spain., Álvarez CV; Neoplasia & Endocrine Differentiation P0L5, Centre for research in Molecular Medicine and Chronic Disease (CIMUS), Av Barcelona s/n, 15782 Santiago de Compostela, Spain., Ildikó V; SeroScience Ltd, Budapest, Hungary., Urbanics R; SeroScience Ltd, Budapest, Hungary; Nanomedicine Research and Education Center, Department of Pathophysiology, Semmelweis University, Budapest, Hungary., Szebeni J; Nanomedicine Research and Education Center, Department of Translational Medicine, Semmelweis University, Budapest 1089, Hungary; Department of Nanobiotechnology and Regenerative Medicine, Faculty of Health Sciences, Miskolc University, Miskolc 2880, Hungary; School of Chemical Engineering and Translational Nanobioscience Research Center, Sungkyunkwan University, Suwon 16419, Republic of Korea., Alonso MJ; Center for Research in Molecular Medicine & Chronic Diseases (CIMUS), University of Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, Spain; Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, Spain; Department of Pharmacology, Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain. Electronic address: mariaj.alonso@usc.es.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Jan 10; Vol. 377, pp. 17-36. Date of Electronic Publication: 2024 Nov 17.
Autor:
Rua, M. (Marta), Simón-Martínez, J.A. (Jon Ander), Collantes, M. (María), Ecay, M. (Margarita), Leiva, J. (José), Carmona-Torre, F. (Francisco de A.), Ramos-Membrive, R. (Rocío), Pareja, F. (Félix), Pulagam, K.R. (Krishna R.), Llop, J. (Jordi), Pozo, J.L. (José Luis) del, Peñuelas-Sanchez, I. (Ivan)
Introduction Suspected infectious diseases located in difficult-to-access sites can be challenging due to the need for invasive procedures to isolate the etiological agent. Positron emission tomography (PET) is a non-invasive imaging technology that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1111::d655521cc34485d1e4478ff81a6a9b34
https://hdl.handle.net/10171/66062
https://hdl.handle.net/10171/66062
Publikováno v:
Dadun. Depósito Académico Digital de la Universidad de Navarra
Consejo Superior de Investigaciones Científicas (CSIC)
Dadun: Depósito Académico Digital de la Universidad de Navarra
Universidad de Navarra
Consejo Superior de Investigaciones Científicas (CSIC)
Dadun: Depósito Académico Digital de la Universidad de Navarra
Universidad de Navarra
Introducción: la nanomedicina avanza en el diseño de nanopartículas para transporte y liberación de fármacos. Un mismo nanotransportador puede combinar agentes terapéuticos y de imagen. El radiomarcaje con radionúclidos es uno de los procedimi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a9ce66cb145745e03cca883f3ede1724
https://hdl.handle.net/10171/61097
https://hdl.handle.net/10171/61097
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Salgueiro, María Jimena1,2 (AUTHOR) jsalgueiro@ffyb.uba.ar, Portillo, Mariano1,2 (AUTHOR), Tesán, Fiorella1 (AUTHOR), Nicoud, Melisa3,4 (AUTHOR), Medina, Vanina3,4 (AUTHOR), Moretton, Marcela2,4,5 (AUTHOR), Chiappetta, Diego2,4,5 (AUTHOR), Zubillaga, Marcela1,2,4 (AUTHOR)
Publikováno v:
EJNMMI Radiopharmacy & Chemistry. 10/29/2024, Vol. 9 Issue 1, p1-17. 17p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Niu Z; Center for Research in Molecular Medicine and Chronic Diseases, IDIS research Institute, Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain., Samaridou E; Center for Research in Molecular Medicine and Chronic Diseases, IDIS research Institute, Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain., Jaumain E; Service de Pharmacologie et d'Immunoanalyse, IBITECS, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France., Coëne J; Service de Pharmacologie et d'Immunoanalyse, IBITECS, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France., Ullio G; Service de Pharmacologie et d'Immunoanalyse, IBITECS, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France., Shrestha N; Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Université Catholique de Louvain, B-1200 Brussels, Belgium., Garcia J; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute for Science and Technology (BIST), 08028 Barcelona, Spain., Durán-Lobato M; Center for Research in Molecular Medicine and Chronic Diseases, IDIS research Institute, Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain., Tovar S; Biomedical Research Group, Center for Research in Molecular Medicine and Chronic Diseases, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain., Santander-Ortega MJ; Cellular Neuroanatomy, Molecular Chemistry of Central Nervous System Group, Faculty of Pharmacy, University of Castilla-La Mancha, 02071 Albacete, Spain; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, Albacete, Spain., Lozano MV; Cellular Neuroanatomy, Molecular Chemistry of Central Nervous System Group, Faculty of Pharmacy, University of Castilla-La Mancha, 02071 Albacete, Spain; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, Albacete, Spain., Arroyo-Jimenez MM; Cellular Neuroanatomy, Molecular Chemistry of Central Nervous System Group, Faculty of Pharmacy, University of Castilla-La Mancha, 02071 Albacete, Spain; Regional Centre of Biomedical Research (CRIB), University of Castilla-La Mancha, Albacete, Spain., Ramos-Membrive R; Radiopharmacy Unit, Department of Nuclear Medicine, Clínica Universidad de Navarra, University Clinic of Navarra, 31008 Pamplona, Spain., Peñuelas I; Radiopharmacy Unit, Department of Nuclear Medicine, Clínica Universidad de Navarra, University Clinic of Navarra, 31008 Pamplona, Spain., Mabondzo A; Service de Pharmacologie et d'Immunoanalyse, IBITECS, CEA, Université Paris-Saclay, F-91191 Gif-sur-Yvette, France., Préat V; Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, Université Catholique de Louvain, B-1200 Brussels, Belgium., Teixidó M; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute for Science and Technology (BIST), 08028 Barcelona, Spain., Giralt E; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute for Science and Technology (BIST), 08028 Barcelona, Spain., Alonso MJ; Center for Research in Molecular Medicine and Chronic Diseases, IDIS research Institute, Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain. Electronic address: mariaj.alonso@usc.es.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2018 Apr 28; Vol. 276, pp. 125-139. Date of Electronic Publication: 2018 Mar 06.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Collantes M; Department of Nuclear Medicine, University of Navarra, Pamplona, Spain - mcollant@unav.es., Barajas M; Hematology-Oncology Research Unit, Foundation for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Cell Therapy Research Unit, Foundation for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain., Quincoces G; Department of Nuclear Medicine, University of Navarra, Pamplona, Spain., Ramos-Membrive R; Department of Nuclear Medicine, University of Navarra, Pamplona, Spain., Martí-Climent JM; Department of Nuclear Medicine, University of Navarra, Pamplona, Spain., Ecay M; Small Animal Imaging Research Unit, Foundation for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain., Rodríguez S; Cell Therapy Research Unit, Foundation for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain., Escalada J; Department of Endocrinology, University of Navarra, Pamplona, Spain., Peñuelas I; Department of Nuclear Medicine, University of Navarra, Pamplona, Spain.; Cell Therapy Research Unit, Foundation for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
Publikováno v:
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.. [Q J Nucl Med Mol Imaging] 2017 Dec; Vol. 61 (4), pp. 447-455. Date of Electronic Publication: 2015 Apr 17.